TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition December 16, 2021
TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies December 3, 2021
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress November 11, 2021
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress August 20, 2021
TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit July 22, 2021
